In this presentation initially presented at the 3rd Annual Highly Potent APIs Summit, Friederike Hermann presents on assessing the risk of exposure, defining the needed containment, and occupational hygiene monitoring in HBEL. 

By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center

Houston, TX facility,Woman working in lab,PD scientist in lab,CGT Houston Process Development
Poster
Novel engineered plasmids and optimized HEK293 cell line improves AAV productivity
Gene therapy developers are under increasing pressure to advance their AAV-based therapeutics for...
Photographer: Martin Oeggerli info@oeggerli.com,,Photo done in Bend site,Lymphocyte and cancer cell,Embryonic stem cells,CarT Cell,EMBRYONIC STEM CELL,Herceptin,Herceptin ,Insulin,Yeast cells,Aspirin,Caffeine crystal,Oxytocin crystal ,Salt crystal,Sodium nitrate,Adeno associated virus,Adenoviruses,Close-up of the center of a flower.,Close-up photo of a green leaf.,Close-up dandelion seeds,macro of oil drops floating on water,Microorganism,Antibody,Cancer Cell and T Lymphocytes,Lipid Nanoparticle,mRNA,Cell Therapy,Exosomes,Lentivirus,Stem cells & iPSC,Viral Vectors,micro image
Article
Ramp up your AAV productivity with novel engineered plasmids and optimized HEK293 cell lines
Lonza has established experience and capabilities in rAAV production and is continually identifying...
Bispecific Molecule
Whitepaper/Executive Summary
Lonza Shapes Biotherapeutics Development Programs Around Different CMC Paths
As protein engineering and manufacturing technologies evolve, small biotech and major pharma...
Shaped Around You Bispecific
Whitepaper/Executive Summary
Accessibility Is A Key Difference In Biotech-CDMO Relationships
The Lonza small biotech series highlights the critical components that innovative Biotechs need to...
Shaped Around You mAb Molecule and hand
Whitepaper/Executive Summary
Flexibility Is A Critical Aspect Of Biotech-CDMO Relationships
The Lonza small biotech series highlights the critical components that smaller innovators need to...
Whitepaper/Executive Summary
Communication Is A Foundation For Effective Biotech-CDMO Relationships
The Lonza small biotech series highlights the critical components that smaller innovators need to...
Presentation (on-demand)
Process development for CGT: How soon is too soon? (Geleen)
During the inaugural event of expanded Process and Analytical Development Laboratories at Lonza...
SM drug product
Webinar (on-demand)
CMC and CDMO: The Importance of Choosing the Right Partner
Small pharma companies are driving pipeline innovation and are increasingly taking more complex...
Whitepaper/Executive Summary
How Can You Ensure Successful Late-Phase Development And Launch Of Your Biologic Drug Product?
Biologics, which are expected to account for over half of all innovative drug sales by 2027, offer...
KC Video thumbnail
Video
Erik Lemay, Servier Video Testimonial
In this video, Erik Lemay, Head of Global External manufacturing at Servier discusses the...
Drug Substance Webinar 2
Presentation (on-demand)
HBEL - Containment and Occupational Hygiene Monitoring
In this presentation initially presented at the 3rd Annual Highly Potent APIs Summit, Friederike...
Bend LMP
Webinar (on-demand)
Multiparticulate Approaches to the Design, Development, and Commercialization of Flexible Dosage...
Multiparticulate technology is seeing increasing use in the pharmaceutical industry to enable...